FDA approves Biogen, Eisai treatment lecanemab
[ad_1] MRI image of brain showing area of Alzheimer patient. Getty Images The Food and Drug Administration on Friday granted accelerated approval for the Alzheimer’s drug lecanemab, the second treatment…